Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TLR7 agonist 2 (TLR7-IN-1) 是选择性 Toll 样受体 7 激动剂,LEC 值为 0.4 μM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,210 | 现货 | ||
2 mg | ¥ 1,880 | 现货 | ||
5 mg | ¥ 3,590 | 现货 | ||
10 mg | ¥ 4,930 | 现货 | ||
25 mg | ¥ 7,900 | 现货 | ||
50 mg | ¥ 10,800 | 现货 | ||
100 mg | ¥ 14,600 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 2,660 | 现货 |
产品描述 | TLR7 agonist 2 (TLR7-IN-1) is a specific and effective Toll-like Receptor 7 (TLR7) agonist (LEC=0.4 μM). |
靶点活性 | TLR7:LEC: 0.4 μM |
体外活性 | In HEK293 cell, Receptor 7 (TLR7) agonist with a lowest effective concentration (LEC) of 0.4 μM. For human TLR8,LEC of TLR7-agonist-1 is >100 μM. For the hERG potassium ion channel 3H-dofetilide,TLR7-agonist-1 has limited inhibition of binding (IC50 >50 μM). |
细胞实验 | The ability of TLR7-agonist-1 to activate human TLR7 and/or TLR8 is assessed by using HEK293 cells. Briefly, HEK293 cells are grown in culture medium (DMEM supplemented with 10% FCS and 2 mM Glutamine). Transfected cells are then detached with Trypsin-EDTA, washed in PBS and resuspended in medium to a density of 1.67×105 cells/mL. Thirty microliters of cells are then dispensed into each well in 384-well plates, where 10 μL of TLR7-agonist-1 in 4% DMSO is already present. Following 6 hours incubation at 37°C, 5% CO2, the luciferase activity is determined by adding 15 μL of Steady Lite Plus substrate to each well and readout performed on a microplate imager. Lowest effective concentrations (LEC) values are determined for TLR7-agonist-1. |
动物实验 | In C57Bl/6 mice model,Single oral administration of 0.3, 1, 3, and 10 mg/kg doses of TLR7-agonist-1. |
别名 | TLR7-agonist-1, TLR7-IN-1 |
分子量 | 336.35 |
分子式 | C17H16N6O2 |
CAS No. | 1642857-69-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (133.79 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.9731 mL | 14.8655 mL | 29.7309 mL | 74.3273 mL |
5 mM | 0.5946 mL | 2.9731 mL | 5.9462 mL | 14.8655 mL | |
10 mM | 0.2973 mL | 1.4865 mL | 2.9731 mL | 7.4327 mL | |
20 mM | 0.1487 mL | 0.7433 mL | 1.4865 mL | 3.7164 mL | |
50 mM | 0.0595 mL | 0.2973 mL | 0.5946 mL | 1.4865 mL | |
100 mM | 0.0297 mL | 0.1487 mL | 0.2973 mL | 0.7433 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
TLR7 agonist 2 1642857-69-9 Immunology/Inflammation TLR inhibit TLR7-agonist-1 TLR-7 agonist 2 Inhibitor TLR7-IN-1 Toll-like Receptor (TLR) inhibitor